arrow_left You’re on the news side, go back to data on Gilead Sciences

Latest news about Gilead Sciences

39 days ago

There has been 19 news about Gilead Sciences in the past from 7 different sources and amongst 2 sections

dataset_white Full dataset

Evolution

Here is the latest:

The New York Times
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Read link
Oct 09, 2024
CNBC News
Here are Monday's biggest analyst calls: Nvidia, Apple, Amazon, Netflix, Campbell Soup, Gilead, American Express & more
Read link
Oct 07, 2024
Times of India
Gilead's tie up with generic cos may not address HIV challenge
Read link
Oct 04, 2024
Times of India
Gilead's tie up with generic cos may not address HIV challenge
Read link
Oct 04, 2024
Dawn
Ferozsons partners with Gilead for HIV drugs
Read link
Oct 04, 2024
Times of India
Dr Reddy's, Hetero ink royalty-free pact with Gilead
Read link
Oct 02, 2024
Times of India
Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir
Read link
Oct 02, 2024
CNBC News
Gilead says its twice-yearly shot cut HIV infections by 96% in trial
Read link
Sep 19, 2024
CNBC News
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
Read link
Aug 20, 2024
Global Issues
Activists Challenge Pharma Company Gilead Over HIV Medication
Read link
Aug 05, 2024

Distribution by section

The coverage span across 2 distinct sections:

Distribution by publisher

There has been 7 publishers reporting on this, here are the top ones:

  • CNBC News (42%)
  • Times of India (21%)
  • The Wall Street Journal (16%)
  • Global Issues (5%)
  • Quartz (5%)

Details

This content can be used under the CC BY 4.0 license